BioSpace News Archive

Concert Pharmaceuticals, Inc. announced that it will host a conference call and webcast event with a key opinion leader in the field of psychiatry and schizophrenia on Thursday, November 14, 2019.

ALX Oncology, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, will present clinical and pharmacodynamic biomarker data from the solid tumor combination cohorts of the ongoing ALX148 Phase 1 clinical program at the SITC 34th Annual Meeting [Abstract P449].

New Analysis of GUIDED Trial Shows GeneSight Test Results Led to Statistically Significant Improvements in Remission, Response and Symptoms

Ionis Pharmaceuticals, Inc. reported its financial results for the third quarter and year-to-date 2019 and recent business highlights..

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral SCD1 modulator currently in a Phase 3/4 clinical trial for the treatment of nonalcoholic steatohepatitis and fibrosis provides a business update and reports financial results for the three and nine months ended September 30, 2019.

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced it will release its unaudited financial results for the quarter ended September 30, 2019 on Monday, November 11, 2019, before the US markets open.

Phase 2 trial will evaluate combination of PD-1 inhibitor Libtayo® (cemiplimab-rwlc) and oncolytic virus Voyager-V1; preclinical research collaboration will explore new oncolytic virus treatments

Incremental Reimbursement in Outpatient Setting Will Expand Availability of Transformative Next-Generation Benign Prostatic Hyperplasia (BPH) Treatment

P-MEC China, co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets, will take place at the Shanghai New International Expo Center from June 22-24, 2020.